Enovis (ENOV) Non Operating Interest Expenses (2010 - 2026)
Enovis' (ENOV) quarterly Non Operating Interest Expenses came in at $8.0 million in Q3 2026, down 13.51% year-over-year from $9.3 million in Q3 2025, and down 12.34% quarter-over-quarter from $9.2 million in Q2 2026.
Analysis
Enovis (ENOV) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Non Operating Interest Expenses for 17 consecutive years, with $8.0 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Non Operating Interest Expenses fell 13.51% year-over-year to $8.0 million in Q3 2026; TTM through Jul 2026 was $33.5 million, a 13.13% decrease from a year earlier, with the FY2025 full-year figure at $34.8 million, down 39.01% from the prior year.
- Non Operating Interest Expenses was $8.0 million for Q3 2026 at Enovis, down from $9.2 million in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $20.0 million in Q1 2024 and troughed at $4.1 million in Q2 2023.
- A 5-year average of $8.5 million and a median of $7.8 million in 2025 frame the typical range for Non Operating Interest Expenses.
- Across the five-year window, Non Operating Interest Expenses tumbled 72.47% in 2022 and surged 316.32% in 2024, its largest moves.
- Over 5 years, Non Operating Interest Expenses stood at $6.1 million in 2022, then sank by 30.37% to $4.3 million in 2023, then soared by 113.24% to $9.1 million in 2024, then slipped by 17.16% to $7.5 million in 2025, then advanced by 6.99% to $8.0 million in 2026.
- The last three Non Operating Interest Expenses figures came in at $8.0 million (Q3 2026), $9.2 million (Q2 2026), and $7.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | 8.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 8.04 Mn |
| Apr 3, 2026 | 9.17 Mn |
| Dec 31, 2025 | 7.51 Mn |
| Oct 3, 2025 | 8.83 Mn |
| Jul 4, 2025 | 9.29 Mn |
| Apr 4, 2025 | 9.19 Mn |
| Dec 31, 2024 | 9.07 Mn |
| Sep 27, 2024 | 11.07 Mn |
| Jun 28, 2024 | 16.97 Mn |
| Mar 29, 2024 | 20.00 Mn |
| Dec 31, 2023 | 4.25 Mn |
| Sep 29, 2023 | 5.77 Mn |
| Jun 30, 2023 | 4.08 Mn |
| Mar 31, 2023 | 5.65 Mn |
| Dec 31, 2022 | 6.11 Mn |
| Sep 30, 2022 | 6.33 Mn |
| Jul 1, 2022 | 4.55 Mn |
| Apr 1, 2022 | 7.06 Mn |
| Dec 31, 2021 | 6.36 Mn |
| Oct 1, 2021 | 4.12 Mn |